NCT00735449 - Comparing Efficacy and Safety of Combigan With Timolol Adjunctive to Xalatan in Glaucoma or Ocular Hypertension Subjects | Biotech Hunter

Enrollment

204

Participants

Timeline

Start Date

July 31, 2008

Primary Completion Date

December 31, 2009

Study Completion Date

December 31, 2009

Conditions

GlaucomaOcular Hypertension

Interventions

DRUG

Fixed combination of brimonidine tartrate 0.2% timolol maleate 0.5%

1 drop of fixed combination of brimonidine tartrate 0.2% timolol maleate 0.5% taken approximately 12 hours apart, up to 2 times a day.

DRUG

timolol maleate 0.5%

1 drop of timolol maleate 0.5% taken approximately 12 hours apart, up to 2 times a day.

DRUG

latanoprost 0.005%

1 drop of latanoprost 0.005% once nightly.

Trial Locations (2)

Newark

Montreal